BRISTOL-MYERS SQUIBB COMPANY Stock-Based Compensation
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Stock-Based Compensation of $281.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $135.00M, a 1.46% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $146.00M, a 1.39% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $133.00M, a 10.83% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $139.00M, a 7.75% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for fiscal 2025 was $553.00M, a 9.07% increase from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for fiscal 2024 was $507.00M, a 2.12% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for fiscal 2023 was $518.00M, a 13.35% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY share-based payment arrangement, noncash expense for fiscal 2022 was $457.00M, a 21.61% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $135.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $281.00M 10-Q · filed 2026-07-30 | $414.00M derived: sum of 3 quarters · filed 2026-07-30 | $553.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $146.00M 10-Q · filed 2026-04-30 | $279.00M derived: sum of 2 quarters · filed 2026-04-30 | $418.00M derived: sum of 3 quarters · filed 2026-04-30 | $555.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $272.00M derived: sum of 2 quarters · filed 2026-02-11 | $409.00M derived: sum of 3 quarters · filed 2026-07-30 | $553.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $139.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $276.00M derived: sum of 2 quarters · filed 2026-07-30 | $420.00M 10-Q · filed 2025-10-30 | $540.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $137.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $281.00M 10-Q · filed 2026-07-30 | $401.00M derived: sum of 3 quarters · filed 2026-07-30 | $530.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $144.00M 10-Q · filed 2026-04-30 | $264.00M derived: sum of 2 quarters · filed 2026-04-30 | $393.00M derived: sum of 3 quarters · filed 2026-04-30 | $518.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $120.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $249.00M derived: sum of 2 quarters · filed 2026-02-11 | $374.00M derived: sum of 3 quarters · filed 2026-02-11 | $507.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $129.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $254.00M derived: sum of 2 quarters · filed 2025-10-30 | $387.00M 10-Q · filed 2025-10-30 | $514.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $125.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $258.00M 10-Q · filed 2025-07-31 | $385.00M derived: sum of 3 quarters · filed 2026-02-11 | $517.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $133.00M 10-Q · filed 2025-04-24 | $260.00M derived: sum of 2 quarters · filed 2026-02-11 | $392.00M derived: sum of 3 quarters · filed 2026-02-11 | $529.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $259.00M derived: sum of 2 quarters · filed 2026-02-11 | $396.00M derived: sum of 3 quarters · filed 2026-02-11 | $518.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $132.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $269.00M derived: sum of 2 quarters · filed 2024-10-31 | $391.00M 10-Q · filed 2024-10-31 | $510.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $137.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $259.00M 10-Q · filed 2024-07-26 | $378.00M derived: sum of 3 quarters · filed 2025-02-12 | $493.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $122.00M 10-Q · filed 2024-04-25 | $241.00M derived: sum of 2 quarters · filed 2025-02-12 | $356.00M derived: sum of 3 quarters · filed 2025-02-12 | $472.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $119.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $234.00M derived: sum of 2 quarters · filed 2025-02-12 | $350.00M derived: sum of 3 quarters · filed 2025-02-12 | $457.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $115.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $231.00M derived: sum of 2 quarters · filed 2023-10-26 | $338.00M 10-Q · filed 2023-10-26 | $471.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $116.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $223.00M 10-Q · filed 2023-07-27 | $356.00M derived: sum of 3 quarters · filed 2024-02-13 | $498.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $107.00M 10-Q · filed 2023-04-27 | $240.00M derived: sum of 2 quarters · filed 2024-02-13 | $382.00M derived: sum of 3 quarters · filed 2024-02-13 | $539.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $275.00M derived: sum of 2 quarters · filed 2024-02-13 | $432.00M derived: sum of 3 quarters · filed 2024-02-13 | $583.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $142.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $299.00M derived: sum of 2 quarters · filed 2022-10-26 | $450.00M 10-Q · filed 2022-10-26 | $621.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $157.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $308.00M 10-Q · filed 2022-07-27 | $479.00M derived: sum of 3 quarters · filed 2023-02-14 | $664.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $151.00M 10-Q · filed 2022-04-29 | $322.00M derived: sum of 2 quarters · filed 2023-02-14 | $507.00M derived: sum of 3 quarters · filed 2023-02-14 | $720.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $356.00M derived: sum of 2 quarters · filed 2023-02-14 | $569.00M derived: sum of 3 quarters · filed 2023-02-14 | $779.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $185.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $398.00M derived: sum of 2 quarters · filed 2021-10-27 | $608.00M 10-Q · filed 2021-10-27 | $892.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $213.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $423.00M 10-Q · filed 2021-07-28 | $707.00M derived: sum of 3 quarters · filed 2022-02-09 | $763.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $210.00M 10-Q · filed 2021-04-29 | $494.00M derived: sum of 2 quarters · filed 2022-02-09 | $550.00M derived: sum of 3 quarters · filed 2022-02-09 | $598.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $284.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $340.00M derived: sum of 2 quarters · filed 2022-02-09 | $388.00M derived: sum of 3 quarters · filed 2022-02-09 | $441.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $56.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $104.00M derived: sum of 2 quarters · filed 2020-11-05 | $157.00M 10-Q · filed 2020-11-05 | $210.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $101.00M 10-Q · filed 2020-08-06 | $154.00M derived: sum of 3 quarters · filed 2021-02-10 | $216.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $53.00M 10-Q · filed 2020-05-07 | $106.00M derived: sum of 2 quarters · filed 2021-02-10 | $168.00M derived: sum of 3 quarters · filed 2021-02-10 | $219.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $115.00M derived: sum of 2 quarters · filed 2021-02-10 | $166.00M derived: sum of 3 quarters · filed 2021-02-10 | $221.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $62.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $113.00M derived: sum of 2 quarters · filed 2019-10-31 | $168.00M 10-Q · filed 2019-10-31 | $218.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $106.00M 10-Q · filed 2019-07-25 | $156.00M derived: sum of 3 quarters · filed 2020-02-24 | $206.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $55.00M 10-Q · filed 2019-04-25 | $105.00M derived: sum of 2 quarters · filed 2020-02-24 | $155.00M derived: sum of 3 quarters · filed 2020-02-24 | $209.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $100.00M derived: sum of 2 quarters · filed 2020-02-24 | $154.00M derived: sum of 3 quarters · filed 2020-02-24 | $199.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $104.00M derived: sum of 2 quarters · filed 2018-10-25 | $149.00M 10-Q · filed 2018-10-25 | $205.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $99.00M 10-Q · filed 2018-07-26 | $155.00M derived: sum of 3 quarters · filed 2019-02-25 | $203.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $45.00M 10-Q · filed 2018-04-26 | $101.00M derived: sum of 2 quarters · filed 2019-02-25 | $149.00M derived: sum of 3 quarters · filed 2019-02-25 | $203.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $56.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $104.00M derived: sum of 2 quarters · filed 2019-02-25 | $158.00M derived: sum of 3 quarters · filed 2019-02-25 | $205.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $102.00M derived: sum of 2 quarters · filed 2017-10-26 | $149.00M 10-Q · filed 2017-10-26 | $208.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $101.00M 10-Q · filed 2017-07-27 | $160.00M derived: sum of 3 quarters · filed 2018-02-13 | $223.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $47.00M 10-Q · filed 2017-04-27 | $106.00M derived: sum of 2 quarters · filed 2018-02-13 | $169.00M derived: sum of 3 quarters · filed 2018-02-13 | $228.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $122.00M derived: sum of 2 quarters · filed 2018-02-13 | $181.00M derived: sum of 3 quarters · filed 2018-02-13 | $235.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $122.00M derived: sum of 2 quarters · filed 2016-10-27 | $176.00M 10-Q · filed 2016-10-27 | $242.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $59.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $113.00M 10-Q · filed 2016-07-28 | $179.00M derived: sum of 3 quarters · filed 2017-02-21 | $227.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $54.00M 10-Q · filed 2016-04-28 | $120.00M derived: sum of 2 quarters · filed 2017-02-21 | $168.00M derived: sum of 3 quarters · filed 2017-02-21 | $218.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $66.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $114.00M derived: sum of 2 quarters · filed 2017-02-21 | $164.00M derived: sum of 3 quarters · filed 2017-02-21 | $213.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $98.00M derived: sum of 2 quarters · filed 2015-10-27 | $147.00M 10-Q · filed 2015-10-27 | $198.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $99.00M 10-Q · filed 2015-07-23 | $150.00M derived: sum of 3 quarters · filed 2016-02-12 | $195.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $49.00M 10-Q · filed 2015-04-28 | $100.00M derived: sum of 2 quarters · filed 2016-02-12 | $145.00M derived: sum of 3 quarters · filed 2016-02-12 | $191.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $96.00M derived: sum of 2 quarters · filed 2016-02-12 | $142.00M derived: sum of 3 quarters · filed 2016-02-12 | $191.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $45.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $91.00M derived: sum of 2 quarters · filed 2014-10-24 | $140.00M 10-Q · filed 2014-10-24 | $186.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $95.00M 10-Q · filed 2014-07-24 | $141.00M derived: sum of 3 quarters · filed 2015-02-13 | $167.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $49.00M 10-Q · filed 2014-04-29 | $95.00M derived: sum of 2 quarters · filed 2015-02-13 | $121.00M derived: sum of 3 quarters · filed 2015-02-13 | $161.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $72.00M derived: sum of 2 quarters · filed 2015-02-13 | $112.00M derived: sum of 3 quarters · filed 2015-02-13 | $154.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $66.00M derived: sum of 2 quarters · filed 2013-10-23 | $108.00M 10-Q · filed 2013-10-23 | $149.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $82.00M 10-Q · filed 2013-07-25 | $123.00M derived: sum of 3 quarters · filed 2014-02-14 | $162.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $42.00M 10-Q · filed 2013-04-25 | $83.00M derived: sum of 2 quarters · filed 2014-02-14 | $122.00M derived: sum of 3 quarters · filed 2014-02-14 | $165.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $80.00M derived: sum of 2 quarters · filed 2014-02-14 | $123.00M derived: sum of 3 quarters · filed 2014-02-14 | $161.00M 10-K · filed 2014-02-14 |
| 2011-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $82.00M derived: sum of 2 quarters · filed 2012-10-24 | $120.00M 10-Q · filed 2012-10-24 | $170.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $81.00M 10-Q · filed 2012-07-25 | $131.00M derived: sum of 3 quarters · filed 2013-02-15 | $178.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $38.00M 10-Q · filed 2012-04-26 | $88.00M derived: sum of 2 quarters · filed 2013-02-15 | $135.00M derived: sum of 3 quarters · filed 2013-02-15 | $184.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $97.00M derived: sum of 2 quarters · filed 2013-02-15 | $146.00M derived: sum of 3 quarters · filed 2013-02-15 | $193.00M 10-K · filed 2013-02-15 |
| 2010-09-30 | $47.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $96.00M derived: sum of 2 quarters · filed 2011-10-27 | $143.00M 10-Q · filed 2011-10-27 | $196.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $96.00M 10-Q · filed 2011-07-28 | $149.00M derived: sum of 3 quarters · filed 2012-02-17 | $191.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $47.00M 10-Q · filed 2011-04-28 | $100.00M derived: sum of 2 quarters · filed 2012-02-17 | $142.00M derived: sum of 3 quarters · filed 2012-02-17 | $187.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $95.00M derived: sum of 2 quarters · filed 2012-02-17 | $140.00M derived: sum of 3 quarters · filed 2012-02-17 | $183.00M 10-K · filed 2012-02-17 |
| 2009-09-30 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $87.00M derived: sum of 2 quarters · filed 2010-10-26 | $130.00M 10-Q · filed 2010-10-26 | $179.00M derived: sum of 4 quarters · filed 2011-02-18 |
| 2009-06-30 | $45.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | $88.00M 10-Q · filed 2010-07-22 | $137.00M derived: sum of 3 quarters · filed 2011-02-18 | $181.00M derived: sum of 4 quarters · filed 2011-02-18 |
| 2009-03-31 | $43.00M 10-Q · filed 2010-04-29 | $92.00M derived: sum of 2 quarters · filed 2011-02-18 | $136.00M derived: sum of 3 quarters · filed 2011-02-18 | |
| 2008-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $93.00M derived: sum of 2 quarters · filed 2011-02-18 | $181.00M 10-K · filed 2011-02-18 | |
| 2008-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $132.00M 10-Q · filed 2009-10-22 | ||
| 2008-06-30 | $88.00M 10-Q · filed 2009-07-23 | |||
| 2007-12-31 | $133.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |